LPItW

22 20 or (19 and 21) (2198)23 limit 22 to (english or french or italian or portuguese or spanish) (2144)24 editorial.pt. (223484)25 23 not 24 (2130)26 (4 or 25) and 16 (249)Database: Embase Search Strategy:1 ((peripher* or central*) and catheter*).ti. (3915)2 (effect* or outcome? or study or prevent* or trial or prophylaxis orassessment).ti. (1670650)3 (child* or infant* or neonat* or premature?).ti. (416851)4 (1 and 2) not 3 (628)5 central venous catheterization/ or vein catheterization/ or blood vesselcatheterization/ (7939)6 extravasation.ti. (1207)7 drug extravasation/ or contrast medium extravasation/ or injection siteextravasation/ (1738)8 6 or 7 (2569)9 (phlebitis or thrombophlebitis or thrombosis).ti. (24086)10 phlebitis/ or injection site phlebitis/ or superficial thrombophlebitis/or thrombophlebitis/ (7568)11 thrombosis/ or catheter thrombosis/ or injection site thrombosis/ or veinthrombosis/ (71287)12 9 or 10 or 11 (89056)13 occlusion.ti. (14465)14 8 or 12 or 13 (105379)15 4 or 5 (8307)16 14 and 15 (1302)17 limit 16 to (embase and (english or french or italian or portuguese orspanish)) (896)18 limit 17 to (evidence based medicine or concensus development or metaanalysis or outcomes research or "systematic review") (58)19 limit 17 to (clinical trial or randomized controlled trial or controlledclinical trial or multicenter study or phase 1 clinical trial or phase 2clinical trial or phase 3 clinical trial or phase 4 clinical trial) (164)20 18 or 19 (190)CINAHLS1 TI ((peripher* or central*) and catheter*)S2 TI ((effect* or outcome* or study or prevent* or trial or prophylaxisor assessmentS3 TI(child* or infant* or neonat* or premature*)S4 (S1 AND S2) NOT S3GPC SOBRE TERAPIA INTRAVENOSA CON DISPOSITIVOS NO PERMANENTES EN ADULTOS 145